ArticleJournal of the American Chemical Society2025
Excision in Two Dimensions: Synthesis of 2D Metal-Organic Nanosheets via Clip-off Chemistry.
Article in Journal of the American Chemical Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Excision in Reduced Dimensionality: Synthesis of 1D Covalent Organic Framework via Clip-off Chemistry.Angewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Two-dimensional metal-organic nanosheets (MONs) combine the topological and chemical versatility of metal-organic frameworks (MOFs) with the advantages of 2D materials, yet their top-down synthesis remains limited mainly to systems with labile coordination bonds. Here, we report a top-down strategy to access MONs from robust 3D MOFs via in-plane covalent bond excision using clip-off chemistry. This approach enables formation of crystalline, porous 2D layers from otherwise nonexfoliable 3D Zr-polycarboxylate frameworks, expanding the scope of accessible MON architectures. Compared to the parent MOF, the resulting MONs exhibit enhanced catalytic performance in esterification reactions, due to the improved exposure of outer active sites.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.